Almokadem S - Search Results

1

A patient with complex multiple genomic ALK alterations.

Liu X, Rice SJ, Jamis-Dow CA, Abendroth C, Ali S, Almokadem S, Belani CP. Liu X, et al. Among authors: almokadem s. Thorax. 2016 Apr;71(4):383-5. doi: 10.1136/thoraxjnl-2015-207950. Epub 2016 Feb 2. Thorax. 2016. PMID: 26839360 No abstract available.

2

Volociximab in cancer.

Almokadem S, Belani CP. Almokadem S, et al. Expert Opin Biol Ther. 2012 Feb;12(2):251-7. doi: 10.1517/14712598.2012.646985. Epub 2011 Dec 22. Expert Opin Biol Ther. 2012. PMID: 22192080 Review.

3

A week in the life of lung cancer survivors: Daily reports of stress, worry, mood, and symptoms.

Aronson KR, Wagstaff DA, Farace E, Muscat J, Belani C, Almokadem S, Fossum T. Aronson KR, et al. Among authors: almokadem s. J Health Psychol. 2016 Oct;21(10):2269-82. doi: 10.1177/1359105315574921. Epub 2015 Apr 6. J Health Psychol. 2016. PMID: 25845832

4

Phase I study of veliparib in combination with gemcitabine.

Stoller R, Schmitz JC, Ding F, Puhalla S, Belani CP, Appleman L, Lin Y, Jiang Y, Almokadem S, Petro D, Holleran J, Kiesel BF, Ken Czambel R, Carneiro BA, Kontopodis E, Hershberger PA, Rachid M, Chen A, Chu E, Beumer JH. Stoller R, et al. Among authors: almokadem s. Cancer Chemother Pharmacol. 2017 Sep;80(3):631-643. doi: 10.1007/s00280-017-3409-3. Epub 2017 Aug 2. Cancer Chemother Pharmacol. 2017. PMID: 28770300 Free PMC article. Clinical Trial.

5

Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer.

Besse B, Tsao LC, Chao DT, Fang Y, Soria JC, Almokadem S, Belani CP. Besse B, et al. Among authors: almokadem s. Ann Oncol. 2013 Jan;24(1):90-6. doi: 10.1093/annonc/mds281. Epub 2012 Aug 16. Ann Oncol. 2013. PMID: 22904239 Free article. Clinical Trial.

6

Impact of genetic markers on treatment of non-small cell lung cancer.

Lamparella N, Barochia A, Almokadem S. Lamparella N, et al. Among authors: almokadem s. Adv Exp Med Biol. 2013;779:145-64. doi: 10.1007/978-1-4614-6176-0_6. Adv Exp Med Biol. 2013. PMID: 23288638 Review.

7

Long-term recurrence-free survival after an unplanned reduction in radiotherapy for HPV-positive oropharyngeal SCC: Two cases and a review of the literature.

Liu J, Goldenberg D, Almokadem S, Crist H, Mackley HB. Liu J, et al. Among authors: almokadem s. Ear Nose Throat J. 2017 Jul;96(7):E23-E27. doi: 10.1177/014556131709600705. Ear Nose Throat J. 2017. PMID: 28719715 Free article. Review.

8

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.

Almokadem S. Almokadem S. Curr Mol Pharmacol. 2016;9(3):226-230. doi: 10.2174/1874467208666150716120658. Curr Mol Pharmacol. 2016. PMID: 26177644 Review.

9

Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.

Fawzy M, Al-Mokadem S, Alshereef M, Elkholy B. Fawzy M, et al. Photodermatol Photoimmunol Photomed. 2024 Jan;40(1):e12929. doi: 10.1111/phpp.12929. Epub 2023 Nov 20. Photodermatol Photoimmunol Photomed. 2024. PMID: 37984828 Clinical Trial.

10

Radiation Alone After Surgery: Avoiding Trimodality Therapy.

Teckie S, Almokadem S. Teckie S, et al. Among authors: almokadem s. Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1027. doi: 10.1016/j.ijrobp.2022.08.066. Int J Radiat Oncol Biol Phys. 2023. PMID: 36922076 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page